Buck9195/awesome-chatgpt-prompts
1
0
Fork 0
mirror of https://github.com/f/awesome-chatgpt-prompts.git synced 2024-12-22 07:09:39 -08:00
Code Issues Projects Releases Packages Wiki Activity Actions
awesome-chatgpt-prompts/LICENSE
ZACHRY T WOODzachryiixixiiwood@gmail.com fa5b5d6400
Update LICENSE
2022-12-13 00:16:08 -06:00

648 lines
35 KiB
Text
Raw Blame History

Thanks for helping make GitHub safe for everyone.
## Security
GitHub takes the security of our software products and services seriously, including all of the open source code repositories managed through our GitHub organizations, such as [GitHub](https://github.com/GitHub).
Even though [open source repositories are outside of the scope of our bug bounty program](https://bounty.github.com/index.html#scope) and therefore not eligible for bounty rewards, we will ensure that your finding gets passed along to the appropriate maintainers for remediation.
## Reporting Security Issues
If you believe you have found a security vulnerability in any GitHub-owned repository, please report it to us through coordinated disclosure.
**Please do not report security vulnerabilities through public GitHub issues, discussions, or pull requests.**
Instead, please send an email to opensource-security[@]github.com.
Please include as much of the information listed below as you can to help us better understand and resolve the issue:
* The type of issue (e.g., buffer overflow, SQL injection, or cross-site scripting)
* Full paths of source file(s) related to the manifestation of the issue
* The location of the affected source code (tag/branch/commit or direct URL)
* Any special configuration required to reproduce the issue
* Step-by-step instructions to reproduce the issue
* Proof-of-concept or exploit code (if possible)
* Impact of the issue, including how an attacker might exploit the issue
This information will help us triage your report more quickly.
## Policy
- Insights
Thank You. #22653
Closed
1 task done
zakwarlord7 opened this issue 1 minute ago · 0 comments
Comments
@zakwarlord7
zakwarlord7 commented 1 minute ago
Code of Conduct
I have read and agree to the GitHub Docs project's Code of Conduct
What article on docs.github.com is affected?
ahaava <3 :
What changes are you suggesting?
tty
Additional information
v,
@zakwarlord7 zakwarlord7 added the content Problems or updates in the docs content on docs.github.com.label 1 minute ago
@zakwarlord7
Author
zakwarlord7 commented 44 seconds ago
Request Date : 07-29-2022
Response Date : 07-29-2022
Tracking Number : 102393399156
Customer File Number : 132624428
Wage and Income Transcript
SSN Provided : XXX-XX-1725
Tax Periood Requested : December, 2020
Form W-2 Wage and Tax Statement
EMployer :
Employer's IDentification Number (EIN) :
INTU
2700 C
Employee :
Reciepient's Identification Number :xxx-xx-1725
ZACH T WOOD
5222 B
Submission Type :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Original document
Wages, Tips and Other Compensation :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5105000.00
eral Income Tax Withheld :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1881380.00
Social Security Wages :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .137700.00
Social Security Tax Withheld :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .853700
Medicare Wages and Tips :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .510500000
Medicare Tax Withheld :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .118166700
Social Security Tips : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .0
Allocated Tips :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .0
Dependent Care Benefits :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .0
Deffered Compensation :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .0
Code "Q" Nontaxable Combat Pay :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .0
Code "W" Employer Contributions tp a Health Savings Account :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .00000
Code "Y" Defferels under a section 409A nonqualified Deferred Compensation plan :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .00000
Code "Z" Income under section 409A on a nonqualified Deferred Compensation plan :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .00000
Code "R" Employer's Contribution to MSA :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...00000
Code "T" Expenses Incurred for Qualified Adoptions :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..00000
Code "V" Income from exercise of non-statutory stock options :. . . . . . . . . . . . . . . . . . . . . . . . . . . . 00000
Code "AA" Designated Roth Contributions under a Section 401 (k) Plan :. . . . . . . . . . . . . . . . . . . ..00000
Code "BB" Designated Roth Contributions under a Section 403 (b) Plan :. . . . . . . . . . . . . . . . . . . . .00000
Code "DD" Cost of Employer-Sponsored Health Coverage :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 00000
Code "EE" Designated ROTH Contributions Under a Governmental Section 457 (b) Plan :
Code "FF" Permitted benefits under a qualified small employer health reimbursment arrangement :$0.00 0
Code "GG" Income from Qualifid Equity Grants Under Section 83 (i) :$0.00
Code "HH" Aggregate Defferals Under section 83(i) Elections as of the Close of the Calendar Year :$0.00
Third Party Sick Pay Indicator :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Unanswered
Retirement Plan Indicator :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . .Unanswered
Statutory Employee :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . .Not Statutory Employee
W2 Submission Type :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...Original document
W2 WHC SSN Validation Code :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Correct SSN
The U.S. Internal Revenue Code of 1986, as amended, the Treasury Regulations promulgated thereunder, published
pronouncements of the Internal Revenue Service, which may be cited or used as precedents, and case law, any of which
may be changed at any time with retroactive effect.
No opinion is expressed on any matters other than those specifically referred to above.
Gross Profit 146698000000 42337000000 37497000000 35653000000 31211000000 30,818,000,000 25,056,000,000 19,744,000,000 22,177,000,000 25,055,000,000 22,931,000,000
Revenue as Reported, Supplemental 257637000000 75325000000 65118000000 61880000000 55314000000 56,898,000,000 46,173,000,000 38,297,000,000 41,159,000,000 46,075,000,000
40,499,000,0 257637000000 75325000000 65118000000 61880000000 55314000000
56,898,000,000 46,173,000,000 38,297,000,000 41,159,000,000 64,133,000,000 34,071,000,000
Other Revenue 6,428,000,000
Cost of Revenue 110939000000 32988000000 27621000000 26227000000 24103000000
-26,080,000,000 -21,117,000,000 -18,553,000,000 -18,982,000,000 -21,020,000,000 -17,568,000,000
Cost of Goods and Services 110939000000 32988000000 27621000000 26227000000 24103000000
-26,080,000,000 -21,117,000,000 -18,553,000,000 -18,982,000,000 -21,020,000,000 -17,568,000,000
Operating Income/Expenses 67984000000 20452000000 16466000000 16292000000 14774000000
-15,167,000,000 -13,843,000,000 -13,361,000,000 -14,200,000,000 -15,789,000,000 -13,754,000,000
Selling, General and Administrative Expenses 36422000000 11744000000 8772000000 8617000000
7289000000 -8,145,000,000 -6,987,000,000 -6,486,000,000 -7,380,000,000 -8,567,000,000
-7,200,000,000
General and Administrative Expenses 13510000000 4140000000 3256000000 3341000000
2773000000 -2,831,000,000 -2,756,000,000 -2,585,000,000 -2,880,000,000 -2,829,000,000
-2,591,000,000
Selling and Marketing Expenses 22912000000 7604000000 5516000000 5276000000 4516000000
-5,314,000,000 -4,231,000,000 -3,901,000,000 -4,500,000,000 -5,738,000,000 -4,609,000,000
Research and Development Expenses 31562000000 8708000000 7694000000 7675000000
7485000000 -7,022,000,000 -6,856,000,000 -6,875,000,000 -6,820,000,000 -7,222,000,000
-6,554,000,000
Total Operating Profit/Loss 78714000000 21885000000 21031000000 19361000000 16437000000
15,651,000,000 11,213,000,000 6,383,000,000 7,977,000,000 9,266,000,000 9,177,000,000
Non-Operating Income/Expenses, Total 12020000000 2517000000 2033000000 2624000000
4846000000 3,038,000,000 2,146,000,000 1,894,000,000 -220,000,000 1,438,000,000 -549,000,000
Total Net Finance Income/Expense 1153000000 261000000 310000000 313000000 269000000
333,000,000 412,000,000 420,000,000 565,000,000 604,000,000 608,000,000
Net Interest Income/Expense 1153000000 261000000 310000000 313000000 269000000
333,000,000 412,000,000 420,000,000 565,000,000 604,000,000 608,000,000
Interest Expense Net of Capitalized Interest 346000000 117000000 77000000 76000000 76000000 -53,000,000 -48,000,000 -13,000,000 -21,000,000 -17,000,000 -23,000,000
Interest Income 1499000000 378000000 387000000 389000000 345000000 386,000,000 460,000,000 433,000,000 586,000,000 621,000,000 631,000,000
Net Investment Income 12364000000 2364000000 2207000000 2924000000 4869000000
3,530,000,000 1,957,000,000 1,696,000,000 -809,000,000 899,000,000 -1,452,000,000
Gain/Loss on Investments and Other Financial Instruments 12270000000 2478000000 2158000000
2883000000 4751000000 3,262,000,000 2,015,000,000 1,842,000,000 -802,000,000 399,000,000
-1,479,000,000
Income from Associates, Joint Ventures and Other Participating Interests 334000000 49000000 188000000
92000000 5000000 355,000,000 26,000,000 -54,000,000 74,000,000 460,000,000 -14,000,000
Gain/Loss on Foreign Exchange 240000000 163000000 139000000 51000000 113000000 -87,000,000 -84,000,000 -92,000,000 -81,000,000 40,000,000 41,000,000
Irregular Income/Expenses 0 0 0 0 0 0 0 0
Other Irregular Income/Expenses 0 0 0 0 0 0 0 0
Other Income/Expense, Non-Operating 1497000000 108000000 484000000 613000000 292000000 -825,000,000 -223,000,000 -222,000,000 24,000,000 -65,000,000 295,000,000
Pretax Income 90734000000 24402000000 23064000000 21985000000 21283000000 18,689,000,000 13,359,000,000 8,277,000,000 7,757,000,000 10,704,000,000 8,628,000,000
Provision for Income Tax 14701000000 3760000000 4128000000 3460000000 3353000000 -3,462,000,000 -2,112,000,000 -1,318,000,000 -921,000,000 -33,000,000 -1,560,000,000
Net Income from Continuing Operations 76033000000 20642000000 18936000000 18525000000 17930000000 15,227,000,000 11,247,000,000 6,959,000,000 6,836,000,000 10,671,000,000 7,068,000,000
Net Income after Extraordinary Items and Discontinued Operations 76033000000 20642000000 18936000000 18525000000 17930000000 15,227,000,000 11,247,000,000 6,959,000,000 6,836,000,000 10,671,000,000 7,068,000,000
Net Income after Non-Controlling/Minority Interests 76033000000 20642000000 18936000000 18525000000 17930000000 15,227,000,000 11,247,000,000 6,959,000,000 6,836,000,000 10,671,000,000 7,068,000,000
Net Income Available to Common Stockholders 76033000000 20642000000 18936000000 18525000000 17930000000 15,227,000,000 11,247,000,000 6,959,000,000 6,836,000,000 10,671,000,000 7,068,000,000
Diluted Net Income Available to Common Stockholders 76033000000 20642000000 18936000000 18525000000 17930000000 15,227,000,000 11,247,000,000 6,959,000,000 6,836,000,000 10,671,000,000 7,068,000,000
Income Statement Supplemental Section
Reported Normalized and Operating Income/Expense Supplemental Section
Total Revenue as Reported, Supplemental 257637000000 75325000000 65118000000 61880000000 55314000000 56,898,000,000 46,173,000,000 38,297,000,000 41,159,000,000 46,075,000,000 40,499,000,000
Total Operating Profit/Loss as Reported, Supplemental 78714000000 21885000000 21031000000 19361000000 16437000000 15,651,000,000 11,213,000,000 6,383,000,000 7,977,000,000 9,266,000,000 9,177,000,000
Reported Effective Tax Rate 0 0 0 0 0 0 0 0
Reported Normalized Income 6,836,000,000
Reported Normalized Operating Profit 7,977,000,000
Other Adjustments to Net Income Available to Common Stockholders
Discontinued Operations
Basic EPS 333.90 31 28 28 27 23 17 10 10 15 10
Basic EPS from Continuing Operations 114 31 28 28 27 22 17 10 10 15 10
Basic EPS from Discontinued Operations
Diluted EPS 3330.90 31 28 27 26 22 16 10 10 15 10
Diluted EPS from Continuing Operations 3330.90 31 28 27 26 22 16 10 10 15
Diluted EPS from Discontinued Operations
Basic Weighted Average Shares Outstanding 667650000 662664000 665758000 668958000 673220000 675,581,000 679,449,000 681,768,000 686,465,000 688,804,000 692,741,000
Diluted Weighted Average Shares Outstanding 677674000 672493000 676519000 679612000 682071000 682,969,000 685,851,000 687,024,000 692,267,000 695,193,000 698,199,000
Reported Normalized Diluted EPS
Basic EPS 114 31 28 28 27 23 17 10 10 15 10
Diluted EPS 112 31 28 27 26 22 16 10 10 15 10
Basic WASO 667650000 662664000 665758000 668958000 673220000 675,581,000 679,449,000 681,768,000 686,465,000 688,804,000 692,741,000
Diluted WASO 677674000 672493000 676519000 679612000 682071000 682,969,000 685,851,000 687,024,000 692,267,000 695,193,000 698,199,000
Fiscal year end September 28th., 2022. | USD
31622,6:39 PM
Morningstar.com Intraday Fundamental Portfolio View Print Report
Print 3/6/2022 at 6:37 PM
Current Value
15,335,150,186,014
GOOGL_income-statement_Quarterly_As_Originally_Reported Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020
Net Cash Flow from Continuing Operating Activities, Indirect 24934000000 25539000000 37497000000 31211000000
30818000000
Cash Generated from Operating Activities 24934000000 25539000000 21890000000
19289000000 22,677,000,000
Income/Loss before Non-Cash Adjustment 20642000000 25539000000 21890000000
19289000000 22,677,000,000
Total Adjustments for Non-Cash Items 6517000000 18936000000 18525000000 17930000000
15,227,000,000
Depreciation, Amortization and Depletion, Non-Cash Adjustment 3439000000 3797000000 4236000000 2592000000 5,748,000,000
Depreciation and Amortization, Non-Cash Adjustment 3439000000 3304000000 2945000000
2753000000 3,725,000,000
Depreciation, Non-Cash Adjustment 3215000000 3304000000 2945000000 2753000000
3,725,000,000
Amortization, Non-Cash Adjustment 224000000 3085000000 2730000000 2525000000
3,539,000,000
Stock-Based Compensation, Non-Cash Adjustment 3954000000 219000000 215000000
228000000 186,000,000
Taxes, Non-Cash Adjustment 1616000000 3874000000 3803000000 3745000000
3,223,000,000
Investment Income/Loss, Non-Cash Adjustment 2478000000 1287000000 379000000
1100000000 1,670,000,000
Gain/Loss on Financial Instruments, Non-Cash Adjustment 2478000000 2158000000 2883000000
4751000000 -3,262,000,000
Other Non-Cash Items 14000000 2158000000 2883000000 4751000000 -3,262,000,000
Changes in Operating Capital 2225000000 64000000 8000000 255000000 392,000,000
Change in Trade and Other Receivables 5819000000 2806000000 871000000 1233000000
1,702,000,000 Change in Trade/Accounts Receivable 5819000000 2409000000
3661000000 2794000000 -5,445,000,000
Change in Other Current Assets 399000000 2409000000 3661000000 2794000000
-5,445,000,000
Change in Payables and Accrued Expenses 6994000000 1255000000 199000000 7000000
-738,000,000
Change in Trade and Other Payables 1157000000 3157000000 4074000000 4956000000
6,938,000,000
Change in Trade/Accounts Payable 1157000000 238000000 130000000 982000000
963,000,000
Change in Accrued Expenses 5837000000 238000000 130000000 982000000 963,000,000
Change in Deferred Assets/Liabilities 368000000 2919000000 4204000000 3974000000
5,975,000,000
Change in Other Operating Capital 3369000000 272000000 3000000 137000000 207,000,000
Change in Prepayments and Deposits 3041000000 1082000000 785000000 740,000,000
Cash Flow from Investing Activities 11016000000
Cash Flow from Continuing Investing Activities 11016000000 10050000000 9074000000
5383000000 -7,281,000,000
Purchase/Sale and Disposal of Property, Plant and Equipment, Net 6383000000 10050000000
9074000000 5383000000 -7,281,000,000
Purchase of Property, Plant and Equipment 6383000000 6819000000 5496000000 5942000000
-5,479,000,000
Sale and Disposal of Property, Plant and Equipment 6819000000 5496000000 5942000000
-5,479,000,000
Purchase/Sale of Business, Net 385000000
Purchase/Acquisition of Business 385000000 259000000 308000000 1666000000 -370,000,000
Purchase/Sale of Investments, Net 4348000000 259000000 308000000 1666000000 -370,000,000
Purchase of Investments 40860000000 3360000000 3293000000 2195000000 -1,375,000,000
Sale of Investments 36512000000 35153000000 24949000000 37072000000 -36,955,000,000
Other Investing Cash Flow 100000000 31793000000 21656000000 39267000000 35,580,000,000
Purchase/Sale of Other Non-Current Assets, Net 388000000 23000000 30000000 -57,000,000
Sales of Other Non-Current Assets
Cash Flow from Financing Activities 16511000000 15254000000
Cash Flow from Continuing Financing Activities 16511000000 15254000000 15991000000 13606000000 -9,270,000,000
Issuance of/Payments for Common Stock, Net 13473000000 12610000000 15991000000 13606000000 -9,270,000,000
Payments for Common Stock 13473000000 12610000000 12796000000 11395000000 -7,904,000,000
Proceeds from Issuance of Common Stock 12796000000 11395000000 -7,904,000,000
Issuance of/Repayments for Debt, Net 115000000 42000000
Issuance of/Repayments for Long Term Debt, Net 115000000 42000000 1042000000 37000000 -57,000,000
Proceeds from Issuance of Long Term Debt 6250000000 6350000000 1042000000 37000000 -57,000,000
Repayments for Long Term Debt 6365000000 6392000000 6699000000 900000000 0
Proceeds from Issuance/Exercising of Stock Options/Warrants 2923000000 2602000000 7741000000 937000000 -57000000 2453000000 2184000000 1647000000-
Other Financing Cash Flow
Cash and Cash Equivalents, End of Period
Change in Cash 0 300000000 10000000 338,000,000,000
Effect of Exchange Rate Changes 20945000000 23719000000 23630000000 26622000000 26,465,000,000
Cash and Cash Equivalents, Beginning of Period 25930000000 235000000000 3175000000 300000000 6,126,000,000
Cash Flow Supplemental Section 181000000000 146000000000 183000000 143000000 210,000,000
Change in Cash as Reported, Supplemental 23719000000000 23630000000000 26622000000000 26465000000000 20,129,000,000,000
Income Tax Paid, Supplemental 2774000000 89000000 2992000000 6,336,000,000
Cash and Cash Equivalents, Beginning of Period 13412000000 157000000 -4,990,000,000
12 Months Ended_________________________________________________________Q42020 Q42019
Income Statement
USD in "000'"s
Repayments for Long Term Debt Dec. 31, 2020 Dec. 31, 2019
Costs and expenses:
Cost of revenues 182527 161,857
Research and development
Sales and marketing 84732 71,896
General and administrative 27573 26,018
European Commission fines 17946 18,464
Total costs and expenses 11052 9,551
Income from operations 0 1,697
Other income (expense), net 141303 127,626
Income before income taxes 41224 34,231
Provision for income taxes 6858000000 5,394
Net income 22677000000 19,289,000,000
*include interest paid, capital obligation, and underweighting 22677000000 19,289,000,000
22677000000 19,289,000,000
Basic net income per share of Class A and B common stock and Class C capital stock (in dollars par share)--
Diluted net income per share of Class A and Class B common stock and Class C capital stock (in dollars par share)
For Paperwork Reduction Act Notice, see the seperate Instructions.
JPMORGAN TRUST III
A/R Aging Summary
As of July 28, 2022
ZACHRY T WOOD
Days over due 31 - 60 61 - 90 91 and over
TOTAL £134,839.00
Alphabet Inc.
Ann. Rev. Date £43,830.00 £43,465.00 £43,100.00 £42,735.00 £42,369.00
Revenues £161,857.00 £136,819.00 £110,855.00 £90,272.00 £74,989.00
Cost of revenues -£71,896.00 -£59,549.00 -£45,583.00 -£35,138.00 -£28,164.00
Gross profit £89,961.00 £77,270.00 £65,272.00 £55,134.00 £46,825.00
Research and development -£26,018.00 -£21,419.00 -£16,625.00 -£13,948.00 -£12,282.00
Sales and marketing -£18,464.00 -£16,333.00 -£12,893.00 -£10,485.00 -£9,047.00
General and administrative -£9,551.00 -£8,126.00 -£6,872.00 -£6,985.00 -£6,136.00
European Commission fines -£1,697.00 -£5,071.00 -£2,736.00 — —
Income from operations £34,231.00 £26,321.00 £26,146.00 £23,716.00 £19,360.00
Interest income
@zakwarlord7 zakwarlord7 closed this as completed :
See [GitHub's Safe Harbor Policy](https://docs.github.com/en/site-policy/security-policies/github-bug-bounty-program-legal-safe-harbor)
Footer
Creative Commons Legal Code
CC0 1.0 Universal
CREATIVE COMMONS CORPORATION IS NOT A LAW FIRM AND DOES NOT PROVIDE
LEGAL SERVICES. DISTRIBUTION OF THIS DOCUMENT DOES NOT CREATE AN
ATTORNEY-CLIENT RELATIONSHIP. CREATIVE COMMONS PROVIDES THIS
INFORMATION ON AN "AS-IS" BASIS. CREATIVE COMMONS MAKES NO WARRANTIES
REGARDING THE USE OF THIS DOCUMENT OR THE INFORMATION OR WORKS
PROVIDED HEREUNDER, AND DISCLAIMS LIABILITY FOR DAMAGES RESULTING FROM
THE USE OF THIS DOCUMENT OR THE INFORMATION OR WORKS PROVIDED
HEREUNDER.
Statement of Purpose
The laws of most jurisdictions throughout the world automatically confer
exclusive Copyright and Related Rights (defined below) upon the creator
and subsequent owner(s) (each and all, an "owner") of an original work of
authorship and/or a database (each, a "Work").
Certain owners wish to permanently relinquish those rights to a Work for
the purpose of contributing to a commons of creative, cultural and
scientific works ("Commons") that the public can reliably and without fear
of later claims of infringement build upon, modify, incorporate in other
works, reuse and redistribute as freely as possible in any form whatsoever
and for any purposes, including without limitation commercial purposes.
These owners may contribute to the Commons to promote the ideal of a free
culture and the further production of creative, cultural and scientific
works, or to gain reputation or greater distribution for their Work in
part through the use and efforts of others.
For these and/or other purposes and motivations, and without any
expectation of additional consideration or compensation, the person
associating CC0 with a Work (the "Affirmer"), to the extent that he or she
is an owner of Copyright and Related Rights in the Work, voluntarily
elects to apply CC0 to the Work and publicly distribute the Work under its
terms, with knowledge of his or her Copyright and Related Rights in the
Work and the meaning and intended legal effect of CC0 on those rights.
1. Copyright and Related Rights. A Work made available under CC0 may be
protected by copyright and related or neighboring rights ("Copyright and
Related Rights"). Copyright and Related Rights include, but are not
limited to, the following:
i. the right to reproduce, adapt, distribute, perform, display,
communicate, and translate a Work;
ii. moral rights retained by the original author(s) and/or performer(s);
iii. publicity and privacy rights pertaining to a person's image or
likeness depicted in a Work;
iv. rights protecting against unfair competition in regards to a Work,
subject to the limitations in paragraph 4(a), below;
v. rights protecting the extraction, dissemination, use and reuse of data
in a Work;
vi. database rights (such as those arising under Directive 96/9/EC of the
European Parliament and of the Council of 11 March 1996 on the legal
protection of databases, and under any national implementation
thereof, including any amended or successor version of such
directive); and
vii. other similar, equivalent or corresponding rights throughout the
world based on applicable law or treaty, and any national
implementations thereof.
2. Waiver. To the greatest extent permitted by, but not in contravention
of, applicable law, Affirmer hereby overtly, fully, permanently,
irrevocably and unconditionally waives, abandons, and surrenders all of
Affirmer's Copyright and Related Rights and associated claims and causes
of action, whether now known or unknown (including existing as well as
future claims and causes of action), in the Work (i) in all territories
worldwide, (ii) for the maximum duration provided by applicable law or
treaty (including future time extensions), (iii) in any current or future
medium and for any number of copies, and (iv) for any purpose whatsoever,
including without limitation commercial, advertising or promotional
purposes (the "Waiver"). Affirmer makes the Waiver for the benefit of each
member of the public at large and to the detriment of Affirmer's heirs and
successors, fully intending that such Waiver shall not be subject to
revocation, rescission, cancellation, termination, or any other legal or
equitable action to disrupt the quiet enjoyment of the Work by the public
as contemplated by Affirmer's express Statement of Purpose.
3. Public License Fallback. Should any part of the Waiver for any reason
be judged legally invalid or ineffective under applicable law, then the
Waiver shall be preserved to the maximum extent permitted taking into
account Affirmer's express Statement of Purpose. In addition, to the
extent the Waiver is so judged Affirmer hereby grants to each affected
person a royalty-free, non transferable, non sublicensable, non exclusive,
irrevocable and unconditional license to exercise Affirmer's Copyright and
Related Rights in the Work (i) in all territories worldwide, (ii) for the
maximum duration provided by applicable law or treaty (including future
time extensions), (iii) in any current or future medium and for any number
of copies, and (iv) for any purpose whatsoever, including without
limitation commercial, advertising or promotional purposes (the
"License"). The License shall be deemed effective as of the date CC0 was
applied by Affirmer to the Work. Should any part of the License for any
reason be judged legally invalid or ineffective under applicable law, such
partial invalidity or ineffectiveness shall not invalidate the remainder
of the License, and in such case Affirmer hereby affirms that he or she
will not (i) exercise any of his or her remaining Copyright and Related
Rights in the Work or (ii) assert any associated claims and causes of
action with respect to the Work, in either case contrary to Affirmer's
express Statement of Purpose.
4. Limitations and Disclaimers.
a. No trademark or patent rights held by Affirmer are waived, abandoned,
surrendered, licensed or otherwise affected by this document.
b. Affirmer offers the Work as-is and makes no representations or
warranties of any kind concerning the Work, express, implied,
statutory or otherwise, including without limitation warranties of
title, merchantability, fitness for a particular purpose, non
infringement, or the absence of latent or other defects, accuracy, or
the present or absence of errors, whether or not discoverable, all to
the greatest extent permissible under applicable law.
c. Affirmer disclaims responsibility for clearing rights of other persons
that may apply to the Work or any use thereof, including without
limitation any person's Copyright and Related Rights in the Work.
Further, Affirmer disclaims responsibility for obtaining any necessary
consents, permissions or other rights required for any use of the
Work.
d. Affirmer understands and acknowledges that Creative Commons is not a
party to this document and has no duty or obligation with respect to
this CC0 or use of the Work.
Reference in a new issue View git blame Copy permalink